Related Experiment Video
Updated: Feb 13, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Luteolin Suppresses Teratoma Cell Growth and Induces Cell Apoptosis via Inhibiting Bcl-2
Teng Liu1, Juan Xu2, Hong Li Yan3
1Department of Pediatric Surgery, Binzhou Medical University Hospital, Binzhou City, Shandong Province, P.R. China.
Abstract:
Luteolin, which is found in plant foods, has a range of therapeutic applications. In order to examine the potential roles of luteolin in ovarian teratocarcinoma, the human ovarian teratocarcinoma cell line PA-1 was selected for functional experiments in vitro and in vivo. We demonstrated that luteolin inhibited the proliferation and colony formation of PA-1 cells in vitro. The flow cytometry results suggested that luteolin induced apoptosis of PA-1 cells in a dose-dependent manner. Immunofluorescence and qRT-PCR results showed that the expression of B-cell lymphoma-2 (Bcl-2) was decreased in luteolin-treated cells, whereas the expression of Bcl-2-associated X (Bax) was increased compared with that in the control group. In addition, luteolin inhibited the tumor growth of ovarian teratocarcinoma cells in a xenograft model. All the results suggested that luteolin induced cell apoptosis and inhibited tumor growth of PA-1 cells.
Insights
Luteolin, a plant-derived compound, effectively inhibits ovarian teratocarcinoma cell growth and promotes apoptosis. This natural compound shows promise in reducing tumor progression in preclinical models.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Luteolin is a flavonoid found in various plant-based foods with known therapeutic properties.
- Ovarian teratocarcinoma is a rare type of germ cell tumor requiring novel therapeutic strategies.
Purpose of the Study:
- To investigate the anti-cancer effects of luteolin on human ovarian teratocarcinoma cells (PA-1).
- To elucidate the molecular mechanisms underlying luteolin's action, including its impact on cell proliferation, apoptosis, and key regulatory proteins.
Main Methods:
- In vitro studies using PA-1 cells to assess proliferation and colony formation.
- Flow cytometry to analyze luteolin-induced apoptosis.
- Immunofluorescence and qRT-PCR to evaluate the expression of apoptosis-related proteins, B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X (Bax).
- In vivo xenograft model to evaluate luteolin's efficacy in inhibiting tumor growth.
Main Results:
- Luteolin significantly inhibited PA-1 cell proliferation and colony formation in vitro.
- Luteolin treatment induced apoptosis in PA-1 cells in a dose-dependent manner.
- Luteolin decreased Bcl-2 expression and increased Bax expression, indicating a shift towards apoptosis.
- Luteolin suppressed ovarian teratocarcinoma tumor growth in a xenograft mouse model.
Conclusions:
- Luteolin demonstrates potent anti-cancer activity against ovarian teratocarcinoma cells.
- Luteolin induces apoptosis and inhibits tumor growth, suggesting its potential as a therapeutic agent for ovarian teratocarcinoma.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Apoptosis
Cells Coordinate Growth and Proliferation
Feedback Inhibition
Adult Stem Cells

